2.095USD+0.39%Mkt Cap: 363.20M USDP/E: 17.42Last update: 2026-06-01
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, engages in developing oral phosphodiesterase-4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon in the United States. Its l…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap363.20M USD
Enterprise Value235.36M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-16.78M USD
Revenue/Share—
Last Price2.095 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees14
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS6963892046
Valuation
P/E (Trailing)17.42
P/E (Forward)-9.02
PEG—
EV/EBITDA-8.88
EV/Revenue—
P/S—
P/B2.79
EPS (TTM)0.12
EPS (Forward)-0.23
52W Range
0.530067% of range2.860
52W High2.860 USD
52W Low0.5300 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-12.97%
ROA-12.49%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.85M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-2.64%
Net Debt-132.63M USD
Net Debt/EBITDA5.01
Balance Sheet
Debt/Equity0.00
Current Ratio23.71
Quick Ratio23.60
Book Value/Sh0.7610 USD
Cash/Share0.7640 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJul 18, 2019
Splits
Last Split1:15
Split DateApr 8, 2024
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)9.714 USD
Target Range5.000 USD – 25.00 USD
# Analysts7
Ownership
Shares Out.173.58M
Float128.36M
Insiders0.03%
Institutions93.46%
Short Interest
Short Ratio6.9d
Short % Float15.51%
Short % Out.15.49%
Shares Short26.92M
Short (prev mo.)25.64M
Technical
SMA 502.007 (+4.4%)
SMA 2001.702 (+23.1%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)3.39M
Avg Vol (10d)2.77M
Technical Indicators
RSI (14)55.9
MACD0.0031
MACD Signal-0.0235
MACD Hist.+0.0266
BB Upper2.148 USD
BB Middle1.945 USD
BB Lower1.741 USD
BB Width20.91%
ATR (14)0.1390 USD
Vol Ratio (20d)0.18x